You are here: Industry Insights > GSK

News List

As Advair generic hits, GSK looks to oncology to spur growth alongside Shingrix, HIV fiercepharma
February 24, 2019
GlaxoSmithKline had several years to prepare for the U.S. generic assault on its respiratory blockbuster Advair, offering discounts and rolling out new therapies to stay in the game.
Bharat buys GSK’s Indian vaccine unit to become largest rabies shot producer fiercepharma
February 19, 2019
India’s Bharat Biotech is about to become the world's largest supplier of rabies vaccines, thanks to a deal to buy Chiron Behring Vaccines from GlaxoSmithKline.
GSK to divest Chiron Behring Vaccines to Bharat Biotech pharmaceutical-technology
February 19, 2019
GlaxoSmithKline (GSK) Asian subsidiary is set to divest its Chiron Behring Vaccines unit in Gujarat, India, to domestic clinical biotechnology company Bharat Biotech.....
Generic Advair will put the squeeze on GSK this year pharmaphorum
February 14, 2019
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business....
GSK closes $5.1bn Tesaro acquisition pharmaceutical-technology
January 24, 2019
GlaxoSmithKline (GSK) has completed its acquisition of US-based biopharmaceutical company Tesaro for an aggregate cash consideration of $5.1bn....
GSK’s chairman Sir Philip Hampton steps down pharmaphorum
January 22, 2019
GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.
With Tesaro in the bag, GSK's cancer pipeline is pumping again fiercepharma
January 10, 2019
When she put cancer back on the front burner last year, GlaxoSmithKline CEO Emma Walmsley gave the company a big task. After all, her predecessor had traded away most of GSK's oncology assets to Novartis.
GSK and Pfizer to create consumer healthcare JV pharmatimes
December 20, 2018
GlaxoSmithKline and Pfizer have unveiled plans to combine their consumer health businesses into a new world-leading Joint Venture worth around £9.8 billion.
GSK and Pfizer to create $13bn consumer healthcare joint venture pharmaceutical-technology
December 20, 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to merge their consumer health businesses to create a new joint venture with an estimated £9.8bn ($12.7bn) in annual sales.....
GlaxoSmithKline weighs men B shot Bexsero's promise against gonorrhea fiercepharma
December 12, 2018
A study showed meningitis B vaccines like GlaxoSmithKline’s Bexsero can provide some protection against gonorrhea, and now the drugmaker is analyzing whether to move forward with testing in the disease area.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page